[Gestagen therapy in male progressive scleroderma (testicular and mammary changes)].
D000328:Adult; D001284:Atrophy; D001706:Biopsy; D005298:Fertility / Q000187:drug effects; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000473:pathology; D013094:Spermatozoa / Q000187:drug effects; D013737:Testis / Q000473:pathology
D009640:Norethindrone
Zur Frage der Gestagentherapie bei der progressiven Sklerodermie des Mannes (Hoden-und Brutsdrüsenveränderungen)